Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Dr Pier Giuseppe discusses stems cells and the important implications they have in the early stages of tumour development. During early tumour development, once an oncogene is expressed in normal cells it induces DNA damage; the cells are pushed into a senescing state. Ultimately the question presented is how stem cells process DNA damage. Findings have started to show that when an oncogene is expressed the stem cells survive early on and DNA activity plays a critical role.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Choosing 1st line TKI Wisely in patients with CML
Addressing the rise of multiple myeloma in Rwanda
ASCO 2024: Lung cancer highlights
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Updates on lung cancer from WCLC and ESMO 2023
OncoAlert round up July 28th to August 3rd, 2023
Haematology malignancies and cellular therapy